Trial intelligence / Profile preview

Concurrent Paclitaxel, Carboplatin, and Radiation Followed by Surgery in Stage IIIA NSCLC

NCT00006469Phase 2Completed

Sponsor
MedStar Health Research Institute
Start
Aug 1999
Primary completion
Jan 2006
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 2 trial of paclitaxel, carboplatin in non-small cell lung cancer (NSCLC), sponsored by MedStar Health Research Institute. Started Aug 1999; status: completed.

02

Drugs

paclitaxelcarboplatin
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT00006469.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00006469.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call